We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 1,571

23andMe insurer claims no duty to defend company

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 7 2014

The insurance carrier that issued a "ProductsCompleted Operations Liability and Professional Liability Policy for Life Sciences" policy to 23andMe

News bytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 7 2014

The U.S. Patent & Trademark Office (USPTO) selects 19 law schools to join its Law School Clinic Certification Pilot Program. Four of the law schools

U.S. senators call on FDA to finalize biosimilars guidance

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 7 2014

Five Republican U.S. senators have written to Health and Human Services (HHS) Secretary Sylvia Burwell to express concerns about the Food and Drug

Corporate venture funding for funding surges

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 7 2014

Silicon Valley Bank (SVB) has issued a report that explores health-care and biotech investments and exits based on 2013 data and concludes, "Large

RICO putative class action dismissed against GNC Corp. and Gencor Nutrients

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 7 2014

A California federal court has dismissed with prejudice a putative class action alleging that GNC Corp., Gencor Nutrients and several individuals

FDA increases drug facility fees

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 7 2014

The U.S. Food and Drug Administration (FDA) has established fiscal year 2015 drug facility user fees that have increased 12-15 percent over current

NIH awards 23andMe $1.4 million grant to build web-based database

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 7 2014

The National Institutes of Health (NIH) has awarded a $1.4 million twoyear grant to personal genome service company 23andMe. The grant is intended to

Physicians urge FDA to allow distinctive names for biosimilars

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 21 2014

A coalition of organizations representing specialist physicians and individual physicians have authored a letter to U.S. Food and Drug Administration

Monell Center studies asthmatic reactions to cognitive odor expectations

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 7 2014

Philadelphia, Pennsylvania-based Monell Chemical Senses Center has published new research suggesting that "simply believing that an odor is

FDA issues warning to star scientific for antabloc and CigRx products

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • January 9 2014

The U.S. Food and Drug Administration (FDA) has warned former Star Scientific, Inc. CEO Jonnie Williams that the company makes therapeutic claims for